LSL Pharma Group, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 90.00% vs 60.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -200.00% vs 50.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.60",
          "val2": "4.00",
          "chgp": "90.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.00",
          "val2": "0.40",
          "chgp": "150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.50",
          "chgp": "60.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "-0.40",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "52.00%",
          "val2": "21.20%",
          "chgp": "3.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.70",
          "val2": "10.00",
          "chgp": "77.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.90",
          "val2": "-3.00",
          "chgp": "163.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "1.80",
          "chgp": "5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.30",
          "val2": "-8.50",
          "chgp": "138.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.90%",
          "val2": "-410.50%",
          "chgp": "43.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

7.60

4.00

90.00%

Operating Profit (PBDIT) excl Other Income

1.00

0.40

150.00%

Interest

0.80

0.50

60.00%

Exceptional Items

-0.80

0.00

Consolidate Net Profit

-1.20

-0.40

-200.00%

Operating Profit Margin (Excl OI)

52.00%

21.20%

3.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 90.00% vs 60.00% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -200.00% vs 50.00% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

17.70

10.00

77.00%

Operating Profit (PBDIT) excl Other Income

1.90

-3.00

163.33%

Interest

1.90

1.80

5.56%

Exceptional Items

0.00

-2.60

100.00%

Consolidate Net Profit

3.30

-8.50

138.82%

Operating Profit Margin (Excl OI)

22.90%

-410.50%

43.34%

USD in Million.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results